Does transcatheter aortic valve implantation reduce all-cause mortality and stroke compared to surgical aortic valve replacement in patients with symptomatic severe aortic stenosis?
TAVI is associated with a reduction in all-cause mortality and stroke up to 2 years compared to SAVR in patients with symptomatic severe aortic stenosis, regardless of baseline surgical risk.
Compared with SAVR, TAVI is associated with reduction in all-cause mortality and stroke up to 2 years irrespective of baseline surgical risk and type of THV system.
Siontis et al. (Sat,) studied this question.